Utility of Shear Wave Elastography for Assessing Allograft Fibrosis in Renal Transplant Recipients: A Pilot Study

2017 ◽  
Vol 37 (6) ◽  
pp. 1455-1465 ◽  
Author(s):  
Heather M. Early ◽  
Ellen C. Cheang ◽  
Jorge M. Aguilera ◽  
Jonah S. W. Hirschbein ◽  
Ghaneh Fananapazir ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Shear Wave ◽  
Shear Wave Elastography ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

Everolimus Conversion to Treat BK Virus Infection in Renal Transplant Recipients: Interim Analysis of a Pilot Study.

2014 ◽  
Vol 98 ◽  
pp. 558-559 ◽  
Author(s):  
D. Wojciechowski ◽  
A. Webber ◽  
S. Chandran ◽  
R. Hirose ◽  
F. Vincenti
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Virus Infection ◽  
Interim Analysis ◽  
Bk Virus ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study

2013 ◽  
Vol 37 (5) ◽  
pp. 481-490 ◽  
Author(s):  
Marcos Ojeda-Cervantes ◽  
Jonatan Barrera-Chimal ◽  
Josefina Alberú ◽  
Rosalba Pérez-Villalva ◽  
Luis Eduardo Morales-Buenrostro ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Pilot Study ◽  
Renal Transplant ◽  
Mineralocorticoid Receptor ◽  
Renal Transplant Recipients ◽  
Receptor Blockade ◽  
Transplant Recipients ◽  
Double Blind ◽  
Mineralocorticoid Receptor Blockade

scholarly journals FP873IMMUNOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT RECIPIENTS - FIVE YEAR DATA OF A PROSPECTIVE RANDOMIZED PILOT STUDY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii369-iii369 ◽  
Author(s):  
Rolf Weimer ◽  
Bogumila Bartylak ◽  
Anne Staak ◽  
Fabrice Renner ◽  
Caner Suesal ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Induction Therapy ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

scholarly journals A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus

2005 ◽  
Vol 5 (1) ◽  
pp. 157-166 ◽  
Author(s):  
E. Steve Woodle ◽  
Flavio Vincenti ◽  
Marc I. Lorber ◽  
H. Albin Gritsch ◽  
Donald Hricik ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients

Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study

2010 ◽  
Vol 42 (4) ◽  
pp. 1308-1311 ◽  
Author(s):  
E. Favi ◽  
G. Spagnoletti ◽  
A. Gargiulo ◽  
M.P. Salerno ◽  
J. Romagnoli ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
De Novo ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Once Daily

scholarly journals An Increase in Myeloid-Related Protein Serum Levels Precedes Acute Renal Allograft Rejection

2001 ◽  
Vol 12 (9) ◽  
pp. 1947-1957
Author(s):  
KLAUS BURKHARDT ◽  
MARTIN RADESPIEL-TRÖGER ◽  
HARALD D. RUPPRECHT ◽  
MARGARETE GOPPELT-STRUEBE ◽  
REGINE RIESS ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Transplant ◽  
Acute Rejection ◽  
High Sensitivity ◽  
Serum Levels ◽  
Renal Transplant Recipients ◽  
Related Protein ◽  
Transplant Recipients ◽  
C Reactive Protein ◽  
Reactive Protein

Abstract. Upon interaction with activated endothelium, monocytes and neutrophils form complexes of myeloid-related protein 8 (MRP8) (S100A8) and MRP14 (S100A9), two members of the calcium-binding S100 family that are secreted during transendothelial migration. In a pilot study of 20 renal transplant recipients and a validation study of 36 renal transplant recipients, MRP8/14 serum levels were measured with an enzyme-linked immunosorbent assay for 28 d, associated with C-reactive protein and creatinine serum levels, and grouped according to biopsy-proven acute rejection. Serum levels of MRP8/14 but not C-reactive protein were significantly increased for several days during the first 2 wk for the acute rejection groups in both studies (P < 0.005, on day 6 after transplantation). As determined by using receiver operating characteristic curves, the optimal cutoff for 100% specificity and high sensitivity (67%) for acute rejection on day 6 after transplantation was calculated to be 4.2 μg/ml for MRP8/14 in the pilot study; this value was confirmed in the validation study. Positive MRP8/14 serum levels preceded acute rejection episodes by a median of 5 d. A 3-d course of intravenous methylprednisolone therapy reduced prerejection MRP8/14 serum levels from 5.7 μg/ml to 3.3 μg/ml (P < 0.05). All MRP8/14 serum levels were below the cutoff during urinary tract infections, delayed graft function, or cytomegalovirus infections, and these values did not differ significantly from control values. It is concluded that the MRP8/14 complex is a very early serum marker suitable for monitoring of acute rejection with high sensitivity and specificity.

Sign in / Sign up

Export Citation Format

Share Document